Kirkland & Ellis advises Bristol-Myers Squibb on its $74 billion acquisition of Celgene, with Simpson Thacher representing JPMorgan and Citigroup as financial advisors to Celgene.
Celgene Corporation sold the stake/assets to Bristol-Myers Squibb Company as part of a acquisition on 2019-01-03.
Deal value was 740000000000 (source: Extracted) Sector: Pharmaceuticals; Location: USA.
On the seller side, Simpson Thacher & Bartlett advised the seller.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Bristol-Myers Squibb on its $74 billion acquisition of Celgene, with Simpson Thacher representing JPMorgan and Citigroup as financial advisors to Celgene. | The Sponsor - The Sponsor
